{"id":454673,"date":"2021-03-10T08:03:26","date_gmt":"2021-03-10T13:03:26","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454673"},"modified":"2021-03-10T08:03:26","modified_gmt":"2021-03-10T13:03:26","slug":"satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/","title":{"rendered":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., March  10, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8LhD1beBOj-F5WNKmpz0VAg3VK2a02_wwmY141rFIIblkK4JkRozgRnZnCT8oFcg58n5eaEPavk_66cH3Xu2pU6eudcGd5XD6PCRMdwssi4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Satsuma Pharmaceuticals, Inc<\/a>. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will present a corporate overview at the 31<sup>st<\/sup> Annual Oppenheimer Healthcare Conference on March 16, 2021 at 3:10 PM Eastern Time. The conference will be held virtually with participants joining remotely from March 16<sup>th<\/sup> to the 18<sup>th<\/sup>.<\/p>\n<p>A webcast of the presentation can be followed live online via the link below: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ks68-vRMqdTusmbsk25M4uBI7HxPTYn6U2ZEDHZywl3TvTf-BQjCRYJ5KGK436Ty6_D0ubNIgyjfPguufX_RXKuehBHuja9p7816_MsHIBYynTMge8K_P8f0thxe4qsId8Bj7xKWoViKs71VjgXVkvJVIKxwOqsl3GbHiozE3Xo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/oppenheimer9\/stsa\/2746007<\/a> or please visit the \u201cEvents and Presentations\u201d page within the \u201cInvestors\u201d section of the Satsuma Pharmaceuticals website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hFoiGctgv-sv1_BFNYpr22kgf8wN8DsQtTjcAuxhZW0DyWd342pxibYe7kPmepznpA-HHoFvxKHNUArCKnC3AA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.satsumarx.com<\/a>.<\/p>\n<p>If you are interested in arranging a one-on-one meeting, please contact your Oppenheimer &amp; Co. Inc. representative or contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5ujsCW-iXe6NJz3obo2MafUbgOnXKSDByt4CtT6eLIkslY45M7xTS8AtGLGI9FZp4NMXaEeaCqqAHFT0flfIJRdnIb_U8hty_ti6gQwZlVYIOZwUttIgMF3wOlNu-pcU8KVe0ttKQqDVNMXLPRKtFiwZ5QINnEgZyYDz8qmPLRrIWyLVDiA7i6cg0SabjbYMsHlHykR-TVASmqTAJEniRQKSHIdX-glcqanCm5Azywc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Corey Davis<\/a> at LifeSci Advisors.<\/p>\n<p>\n        <strong>About Satsuma Pharmaceuticals and STS101<\/strong>\n      <\/p>\n<p align=\"justify\">Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, nasal delivery device. DHE products have long been recommended as a first-line therapeutic option for the acute treatment of migraine and have significant advantages over other therapeutics for many patients. However, broad use has been limited by invasive and burdensome administration and\/or sub-optimal clinical performance of available injectable and liquid nasal spray products. STS101 is in Phase 3 development and specifically designed to deliver the clinical advantages of DHE while overcoming these shortcomings.<\/p>\n<p>Satsuma is headquartered in South San Francisco, California with operations in both California and Research Triangle Park, North Carolina. For further information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hFoiGctgv-sv1_BFNYpr29xofauzgMsOudstS-h1VuoxY9tT1AgStLuYtD3XK_UZvZuCd7qXjDBmuuHYIq08cA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.satsumarx.com<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>INVESTOR AND CORPORATE CONTACTS<\/u><br \/>\n        <\/strong><br \/>\n        <strong>: <\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>Corey Davis, PhD<br \/>LifeSci Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F66G8xEk4cRLxpybD7RCbzB0plDWiT1R8qD1roKL_zLbVDhGDaS8PqIG-zvkEjBhm3eSRlPr22lw-MkGMKGbSiT_qqCriQtMraUrpzDSOx6bbyv92xvZ57tm06K7bQlV\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">cdavis@lifesciadvisors.com<\/a><\/p>\n<p>Tom O\u2019Neil, Chief Financial Officer<br \/>Satsuma Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1HxQ738bDpJbRBV-MfCwPD20M3lB8QnsYQYzKHkd72i2Q32rvx0nlHMGIoEAsO2fO9H9G75uI2E5MLA0ne7Eg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">tom@satsumarx.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/28c33f22-3b53-4744-85d4-3fc5f3c67f38\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will present a corporate overview at the 31st Annual Oppenheimer Healthcare Conference on March 16, 2021 at 3:10 PM Eastern Time. The conference will be held virtually with participants joining remotely from March 16th to the 18th. A webcast of the presentation can be followed live online via the link below: https:\/\/wsw.com\/webcast\/oppenheimer9\/stsa\/2746007 or please visit the \u201cEvents and Presentations\u201d page within the \u201cInvestors\u201d section of the Satsuma Pharmaceuticals website at www.satsumarx.com. If you are interested in arranging a one-on-one meeting, please contact your Oppenheimer &amp; Co. Inc. representative or contact Corey Davis at LifeSci Advisors. About Satsuma &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454673","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will present a corporate overview at the 31st Annual Oppenheimer Healthcare Conference on March 16, 2021 at 3:10 PM Eastern Time. The conference will be held virtually with participants joining remotely from March 16th to the 18th. A webcast of the presentation can be followed live online via the link below: https:\/\/wsw.com\/webcast\/oppenheimer9\/stsa\/2746007 or please visit the \u201cEvents and Presentations\u201d page within the \u201cInvestors\u201d section of the Satsuma Pharmaceuticals website at www.satsumarx.com. If you are interested in arranging a one-on-one meeting, please contact your Oppenheimer &amp; Co. Inc. representative or contact Corey Davis at LifeSci Advisors. About Satsuma &hellip; Continue reading &quot;Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T13:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference\",\"datePublished\":\"2021-03-10T13:03:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/\",\"name\":\"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\",\"datePublished\":\"2021-03-10T13:03:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will present a corporate overview at the 31st Annual Oppenheimer Healthcare Conference on March 16, 2021 at 3:10 PM Eastern Time. The conference will be held virtually with participants joining remotely from March 16th to the 18th. A webcast of the presentation can be followed live online via the link below: https:\/\/wsw.com\/webcast\/oppenheimer9\/stsa\/2746007 or please visit the \u201cEvents and Presentations\u201d page within the \u201cInvestors\u201d section of the Satsuma Pharmaceuticals website at www.satsumarx.com. If you are interested in arranging a one-on-one meeting, please contact your Oppenheimer &amp; Co. Inc. representative or contact Corey Davis at LifeSci Advisors. About Satsuma &hellip; Continue reading \"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T13:03:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference","datePublished":"2021-03-10T13:03:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/","name":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==","datePublished":"2021-03-10T13:03:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzM2NSM0MDU2NjY1IzUwMDA2OTEyMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/satsuma-pharmaceuticals-to-present-at-the-31st-annual-oppenheimer-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Satsuma Pharmaceuticals to Present at the 31st Annual Oppenheimer Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454673"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454673\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}